The 50 mg vial is reconstituted with 2 mL of bacteriostatic water to achieve a 25 mg/mL concentration (0.25 mg per unit)
DSIP Dosage Guide DSIP is not currently approved for human use and there are no official dosing guidelines in place for this compound
Once reconstituted, peptide solutions should be stored at 28C and used within the manufacturer-specified stability window
Full AI Image Prompt: Create a clinical safety infographic titled GHK-Cu Safety Considerations by Route. Use a three-column matrix labeled Topical products, Wound-care study context, and Injectable or compounded preparations. Under topical products, include skin irritation, allergic reaction, and formulation sensitivity. Under wound-care study context, include study exclusions, copper or peptide sensitivity, and dressings or adhesives. Under injectable or compounded preparations, include limited human safety data, peptide-related impurities, aggregation risk, and immunogenicity risk. Use a calm medical style, white background, simple icons, and subtle copper-blue accents
Always consult with a medical professional to determine the best dosage and administration plan for your specific needs
It may be pointed out here that earlier reports are available in literature which have demonstrated the enzyme-catalysed formation of dityrosine from tyrosine 7